2-Arylbenzo[b]furan Derivatives As Potent Human Lipoxygenase Inhibitors

Li Lang,Ningning Dong,Deyan Wu,Xue Yao,Weiqiang Lu,Chen Zhang,Ping Ouyang,Jin Zhu,Yun Tang,Wei Wang,Jian Li,Jin Huang
DOI: https://doi.org/10.1080/14756366.2016.1220376
2016-01-01
Journal of Enzyme Inhibition and Medicinal Chemistry
Abstract:Human lipoxygenases (LOXs) have been emerging as effective therapeutic targets for inflammatory diseases. In this study, we found that four natural 2-arylbenzo[b]furan derivatives isolated from Artocarpus heterophyllus exhibited potent inhibitory activities against human LOXs, including moracin C (1), artoindonesianin B-1 (2), moracin D (3), moracin M (4). In our in vitro experiments, compound 1 was identified as the most potent LOX inhibitor and the moderate subtype selective inhibitor of 12-LOX. Compounds 1 and 2 act as competitive inhibitors of LOXs. Moreover, 1 significantly inhibits LTB4 production and chemotactic capacity of neutrophils, and is capable of protecting vascular barrier from plasma leakage in vivo. In addition, the preliminary structure-activity relationship analysis was performed based on the above four naturally occurring (1-4) and six additional synthetic 2-arylbenzo[b]furan derivatives. Taken together, these 2-arylbenzo[b]furan derivatives, as LOXs inhibitors, could represent valuable leads for the future development of therapeutic agents for inflammatory diseases.
What problem does this paper attempt to address?